96 related articles for article (PubMed ID: 15019163)
1. Loss of heterozygosity and p53 expression in Pterygium.
Reisman D; McFadden JW; Lu G
Cancer Lett; 2004 Mar; 206(1):77-83. PubMed ID: 15019163
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress in pterygium: relationship between p53 and 8-hydroxydeoxyguanosine.
Perra MT; Maxia C; Corbu A; Minerba L; Demurtas P; Colombari R; Murtas D; Bravo S; Piras F; Sirigu P
Mol Vis; 2006 Sep; 12():1136-42. PubMed ID: 17093398
[TBL] [Abstract][Full Text] [Related]
3. Generation of loss of heterozygosity and its dependency on p53 status in human lymphoblastoid cells.
Honma M
Environ Mol Mutagen; 2005; 45(2-3):162-76. PubMed ID: 15688360
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity and p53 expression in pterygia.
Shimmura S; Ishioka M; Hanada K; Shimazaki J; Tsubota K
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1364-9. PubMed ID: 10798651
[TBL] [Abstract][Full Text] [Related]
5. P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium.
Tsai YY; Cheng YW; Lee H; Tsai FJ; Tseng SH; Chang KC
Mol Vis; 2005 Jan; 11():50-5. PubMed ID: 15682042
[TBL] [Abstract][Full Text] [Related]
6. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
7. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer.
Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC
Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146
[TBL] [Abstract][Full Text] [Related]
8. Aberrant p53 protein expression and function in a panel of hematopoietic cell lines with different p53 mutations.
Kamihira S; Terada C; Sasaki D; Yanagihara K; Tsukasaki K; Hasegawa H; Yamada Y
Eur J Haematol; 2009 Apr; 82(4):301-7. PubMed ID: 19220422
[TBL] [Abstract][Full Text] [Related]
9. An association between BPDE-like DNA adduct levels and P53 gene mutation in pterygium.
Lai TJ; Tsai YY; Cheng YW; Chiang CC; Lee H; Chou MC; Chang JH
Mol Vis; 2006 Dec; 12():1687-91. PubMed ID: 17213797
[TBL] [Abstract][Full Text] [Related]
10. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of p53 protein in pterygia is not accompanied by TP53 gene mutation.
Schneider BG; John-Aryankalayil M; Rowsey JJ; Dushku N; Reid TW
Exp Eye Res; 2006 Jan; 82(1):91-8. PubMed ID: 16005868
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic alterations and viral presence in ophthalmic pterygium.
Detorakis ET; Drakonaki EE; Spandidos DA
Int J Mol Med; 2000 Jul; 6(1):35-41. PubMed ID: 10851263
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma.
Hu N; Flaig MJ; Su H; Shou JZ; Roth MJ; Li WJ; Wang C; Goldstein AM; Li G; Emmert-Buck MR; Taylor PR
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6013-22. PubMed ID: 15447985
[TBL] [Abstract][Full Text] [Related]
15. SW480, a p53 double-mutant cell line retains proficiency for some p53 functions.
Rochette PJ; Bastien N; Lavoie J; Guérin SL; Drouin R
J Mol Biol; 2005 Sep; 352(1):44-57. PubMed ID: 16061257
[TBL] [Abstract][Full Text] [Related]
16. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines.
Liu Y; Bodmer WF
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):976-81. PubMed ID: 16418264
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of p53 enhances transcription-coupled repair and global genomic repair of a UVC-damaged reporter gene in human cells.
Dregoesc D; Rybak AP; Rainbow AJ
DNA Repair (Amst); 2007 May; 6(5):588-601. PubMed ID: 17196445
[TBL] [Abstract][Full Text] [Related]
18. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death.
Kim LH; Peh SC; Poppema S
Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421
[TBL] [Abstract][Full Text] [Related]
19. Frequent retention of heterozygosity for point mutations in p53 and Ikaros in N-ethyl-N-nitrosourea-induced mouse thymic lymphomas.
Kakinuma S; Nishimura M; Kubo A; Nagai JY; Amasaki Y; Majima HJ; Sado T; Shimada Y
Mutat Res; 2005 May; 572(1-2):132-41. PubMed ID: 15790496
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional responses to ionizing radiation reveal that p53R2 protects against radiation-induced mutagenesis in human lymphoblastoid cells.
Tsai MH; Chen X; Chandramouli GV; Chen Y; Yan H; Zhao S; Keng P; Liber HL; Coleman CN; Mitchell JB; Chuang EY
Oncogene; 2006 Jan; 25(4):622-32. PubMed ID: 16247478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
